Aptus Endosystems Obtains $30,000,000 Series C Round

  • Feed Type
  • Date
  • Company Name
    Aptus Endosystems
  • Mailing Address
    777 N. Pastoria Avenue Sunnyvale, CA 94085-2918
  • Company Description
    Aptus Endosystems is a privately held, well-funded, emerging medical device company that is engaged in the development of next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of Abdominal Aortic Aneurysm – the 13th leading cause of death in the United States and the 10th leading cause of death in men over the age of 55.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company said in a prepared statement that it plans to use the proceeds to help complete its U.S. clinical study and file for a subsequent premarket approval with the U.S. Food and Drug Administration.
  • M&A Terms
  • Venture Investor
    Heron Capital
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    Prism VentureWorks
  • Venture Investor
    Baird Venture Partners
  • Venture Investor
    FirstMark Capital
  • Venture Investor

Trending on Xconomy